Global economic cost of smoking-attributable diseases
- PMID: 28138063
- PMCID: PMC5801657
- DOI: 10.1136/tobaccocontrol-2016-053305
Global economic cost of smoking-attributable diseases
Erratum in
-
Correction: Global economic cost of smoking-attributable diseases.Tob Control. 2018 Jul;27(4):478. doi: 10.1136/tobaccocontrol-2016-053305corr1. Epub 2018 Jun 16. Tob Control. 2018. PMID: 31329655 Free PMC article.
Abstract
Background: The detrimental impact of smoking on health has been widely documented since the 1960s. Numerous studies have also quantified the economic cost that smoking imposes on society. However, these studies have mostly been in high income countries, with limited documentation from developing countries. The aim of this paper is to measure the economic cost of smoking-attributable diseases in countries throughout the world, including in low- and middle-income settings.
Methods: The Cost of Illness approach is used to estimate the economic cost of smoking attributable-diseases in 2012. Under this approach, economic costs are defined as either 'direct costs' such as hospital fees or 'indirect costs' representing the productivity loss from morbidity and mortality. The same method was applied to 152 countries, which had all the necessary data, representing 97% of the world's smokers.
Findings: The amount of healthcare expenditure due to smoking-attributable diseases totalled purchasing power parity (PPP) $467 billion (US$422 billion) in 2012, or 5.7% of global health expenditure. The total economic cost of smoking (from health expenditures and productivity losses together) totalled PPP $1852 billion (US$1436 billion) in 2012, equivalent in magnitude to 1.8% of the world's annual gross domestic product (GDP). Almost 40% of this cost occurred in developing countries, highlighting the substantial burden these countries suffer.
Conclusions: Smoking imposes a heavy economic burden throughout the world, particularly in Europe and North America, where the tobacco epidemic is most advanced. These findings highlight the urgent need for countries to implement stronger tobacco control measures to address these costs.
Keywords: Economics; Global health; Smoking Caused Disease.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- USDHHS. The health consequences of smoking: a report to the Surgeon General. Washington DC, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
-
- WHO. Economics of tobacco toolkit: assessment of the economic costs of smoking. Geneva, World Health Organization, 2011.
-
- UN. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York: United Nations General Assembly, 2012.
-
- UN. Transforming our World: the 2030 Agenda for Sustainable Development. New York: United National General Assembly, 2015.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical